University of Cologne: Inhibiting Programmed Cell Death to Treat a Rare Childhood Disease
August 22, 2025
August 22, 2025
KOLN, Germany, Aug. 22 (TNSjou) -- The University of Cologne issued the following news release:
* * *
Inhibiting programmed cell death to treat a rare childhood disease
A preclinical study at the University of Cologne could open up new treatment options for STING-associated vasculopathy with onset in infancy (SAVI) and benefit a wide spectrum of other currently therapy-resistant genetic diseases / publication in "Nature"
*
* * *
Inhibiting programmed cell death to treat a rare childhood disease
A preclinical study at the University of Cologne could open up new treatment options for STING-associated vasculopathy with onset in infancy (SAVI) and benefit a wide spectrum of other currently therapy-resistant genetic diseases / publication in "Nature"
*